Is BACPX or JNJ a better dividend investment in 2026?

BACPX currently yields 4.15% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BACPX offers higher current income.

What is the dividend yield difference between BACPX and JNJ?

BACPX has a forward dividend yield of 4.15% ($0.47/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.79 percentage points.

Home › Compare › BACPX vs JNJ

BACPX vs JNJ: Dividend Comparison 2026

BACPX yields 4.15% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BACPX wins by $6.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BACPX

● Live price

4.15%

Share price

$11.37

Annual div

$0.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.2K

Annual income

$541.24

Full BACPX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BACPX vs JNJ

📍 BACPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BACPX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BACPX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BACPX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BACPX

Annual income on $10K today (after 15% tax)

$352.55/yr

After 10yr DRIP, annual income (after tax)

$460.05/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $243.56/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BACPX + JNJ for your $10,000?

BACPX: 50%JNJ: 50%

100% JNJ50/50100% BACPX

Portfolio after 10yr

$23.1K

Annual income

$684.51/yr

Blended yield

2.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BACPX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BACPX buys

JNJ buys

No recent congressional trades found for BACPX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBACPXJNJ

Forward yield	4.15% ✓	3.36%
Annual dividend / share	$0.47	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$26.2K ✓	$20.0K
Annual income after 10y	$541.24	$827.78 ✓
Total dividends collected	$4.8K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BACPX vs JNJ ($10,000, DRIP)

Year	BACPX Portfolio	BACPX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,115	$414.77	$10,676	$355.77	+$439.00 → BACPX
2	$12,324	$430.84	$11,407	$389.39	+$917.00 → BACPX
3	$13,633	$446.45	$12,198	$426.53	+$1.4K → BACPX
4	$15,049	$461.57	$13,056	$467.62	+$2.0K → BACPX
5	$16,578	$476.17	$13,987	$513.12	+$2.6K → BACPX
6	$18,229	$490.26	$14,998	$563.56	+$3.2K → BACPX
7	$20,009	$503.80	$16,098	$619.52	+$3.9K → BACPX
8	$21,926	$516.82	$17,295	$681.69	+$4.6K → BACPX
9	$23,990	$529.29	$18,599	$750.82	+$5.4K → BACPX
10	$26,211	$541.24	$20,022	$827.78	+$6.2K → BACPX

BACPX vs JNJ: Complete Analysis 2026

BACPX — Stock

The fund, which is a fund of funds, normally the advisor intends to obtain exposure to equity securities (and certain other instruments) in an amount equal to 20% of its assets and exposure to fixed-income securities in an amount equal to 80% of its assets. Normally, the advisor intends to invest primarily in affiliated open-end funds and affiliated ETFs. The fund may have indirect exposure to derivative instruments through its investments in certain underlying funds.

Full BACPX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BACPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BACPX vs SCHD BACPX vs JEPI BACPX vs O BACPX vs KO BACPX vs MAIN BACPX vs ABBV BACPX vs MRK BACPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.